These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Perspectives for integrating human and environmental risk assessment and synergies with socio-economic analysis. Péry AR; Schüürmann G; Ciffroy P; Faust M; Backhaus T; Aicher L; Mombelli E; Tebby C; Cronin MT; Tissot S; Andres S; Brignon JM; Frewer L; Georgiou S; Mattas K; Vergnaud JC; Peijnenburg W; Capri E; Marchis A; Wilks MF Sci Total Environ; 2013 Jul; 456-457():307-16. PubMed ID: 23624004 [TBL] [Abstract][Full Text] [Related]
24. Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools. Griesinger C; Desprez B; Coecke S; Casey W; Zuang V Adv Exp Med Biol; 2016; 856():65-132. PubMed ID: 27671720 [TBL] [Abstract][Full Text] [Related]
25. Integrated Approaches to Testing and Assessment. Casati S Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():51-55. PubMed ID: 29604238 [TBL] [Abstract][Full Text] [Related]
26. Proposal to improve vertebrate cell cultures to establish them as substitutes for the regulatory testing of chemicals and effluents using fish. Schirmer K Toxicology; 2006 Jul; 224(3):163-83. PubMed ID: 16765501 [TBL] [Abstract][Full Text] [Related]
27. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status. Ukelis U; Kramer PJ; Olejniczak K; Mueller SO Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045 [TBL] [Abstract][Full Text] [Related]
28. Validation of innovative technologies and strategies for regulatory safety assessment methods: challenges and opportunities. Stokes WS; Wind M ALTEX; 2010; 27(3):87-95. PubMed ID: 21113563 [TBL] [Abstract][Full Text] [Related]
29. Gaining acceptance for the use of in vitro toxicity assays and QIVIVE in regulatory risk assessment. Meek ME; Lipscomb JC Toxicology; 2015 Jun; 332():112-23. PubMed ID: 25598226 [TBL] [Abstract][Full Text] [Related]
30. Dose metric considerations in in vitro assays to improve quantitative in vitro-in vivo dose extrapolations. Groothuis FA; Heringa MB; Nicol B; Hermens JL; Blaauboer BJ; Kramer NI Toxicology; 2015 Jun; 332():30-40. PubMed ID: 23978460 [TBL] [Abstract][Full Text] [Related]
31. Integrated testing strategies for use in the EU REACH system. Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF Altern Lab Anim; 2006 Aug; 34(4):407-27. PubMed ID: 16945008 [TBL] [Abstract][Full Text] [Related]
32. Novel strategies for toxicological risk assessments. Roy A; Akbarsha MA ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760 [No Abstract] [Full Text] [Related]
33. Successful validation of in vitro methods in toxicology by ZEBET, the National Centre for Alternatives in Germany at the BfR (Federal Institute for Risk Assessment). Spielmann H; Grune B; Liebsch M; Seiler A; Vogel R Exp Toxicol Pathol; 2008 Jun; 60(2-3):225-33. PubMed ID: 18440212 [TBL] [Abstract][Full Text] [Related]
34. Alternative approaches to vertebrate ecotoxicity tests in the 21st century: A review of developments over the last 2 decades and current status. Lillicrap A; Belanger S; Burden N; Pasquier DD; Embry MR; Halder M; Lampi MA; Lee L; Norberg-King T; Rattner BA; Schirmer K; Thomas P Environ Toxicol Chem; 2016 Nov; 35(11):2637-2646. PubMed ID: 27779828 [TBL] [Abstract][Full Text] [Related]
35. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME. Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968 [TBL] [Abstract][Full Text] [Related]
36. Development of alternative methods. Goldberg AM J Toxicol Sci; 1995 Sep; 20(4):443-9. PubMed ID: 8531238 [TBL] [Abstract][Full Text] [Related]
37. State of the art on alternative methods to animal testing from an industrial point of view: ready for regulation? Ashton R; De Wever B; Fuchs HW; Gaca M; Hill E; Krul C; Poth A; Roggen EL ALTEX; 2014; 31(3):357-63. PubMed ID: 24819539 [TBL] [Abstract][Full Text] [Related]
38. The long and winding road of progress in the use of in vitro data for risk assessment purposes: From "carnation test" to integrated testing strategies. Blaauboer BJ Toxicology; 2015 Jun; 332():4-7. PubMed ID: 24769060 [TBL] [Abstract][Full Text] [Related]
39. Assuring safety without animal testing: the case for the human testis in vitro. Chapin RE; Boekelheide K; Cortvrindt R; van Duursen MB; Gant T; Jegou B; Marczylo E; van Pelt AM; Post JN; Roelofs MJ; Schlatt S; Teerds KJ; Toppari J; Piersma AH Reprod Toxicol; 2013 Aug; 39():63-8. PubMed ID: 23612449 [TBL] [Abstract][Full Text] [Related]
40. Report of the EPAA-ECVAM workshop on the validation of Integrated Testing Strategies (ITS). Kinsner-Ovaskainen A; Maxwell G; Kreysa J; Barroso J; Adriaens E; Alépée N; Berg N; Bremer S; Coecke S; Comenges JZ; Corvi R; Casati S; Dal Negro G; Marrec-Fairley M; Griesinger C; Halder M; Heisler E; Hirmann D; Kleensang A; Kopp-Schneider A; Lapenna S; Munn S; Prieto P; Schechtman L; Schultz T; Vidal JM; Worth A; Zuang V Altern Lab Anim; 2012 Jul; 40(3):175-81. PubMed ID: 22943518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]